Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9850
-0.0450 (-4.37%)
Jun 30, 2026, 3:13 PM EDT - Market open
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $42.39 million as of June 30, 2026. Its market cap has increased by 17.65% in one year.
Market Cap
42.39M
Enterprise Value
42.40M
1-Year Change
17.65%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $42.39M, an increase of 2,284.60%. That is a compound annual growth rate of 136.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 42.29M | -28.21% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 50.08M |
| Hyperion DeFi | 48.20M |
| Eloxx Pharmaceuticals | 48.15M |
| Apollomics | 46.64M |
| Radiopharm Theranostics | 46.34M |
| Metagenomi Therapeutics | 45.18M |
| RenovoRx | 43.75M |
| INmune Bio | 43.07M |